Drug Type Chemical drugs |
Synonyms (5,6-Dimethylbenzimidazolyl)cobamide coenzyme, 5'-Deoxy-5'-adenosylcobalamin, 5, 6‒dimethylbenzimidazolylcobamide coenzyme + [13] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (19 Jan 1967), |
Regulation- |
Molecular FormulaC72H100CoN18O17P |
InChIKeyDWKMERNBNCCNEZ-RQKYJTTQSA-M |
CAS Registry13870-90-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00042 | Cobamamide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Nutrition Disorders | CN | 01 Jan 1995 | |
Anemia, Pernicious | JP | 19 Jan 1967 | |
Arthralgia | JP | 19 Jan 1967 | |
Central Nervous System Diseases | JP | 19 Jan 1967 | |
Facial Paralysis | JP | 19 Jan 1967 | |
Leukopenia | JP | 19 Jan 1967 | |
Malabsorption Syndromes | JP | 19 Jan 1967 | |
Myalgia | JP | 19 Jan 1967 | |
Neuralgia | JP | 19 Jan 1967 | |
Neuritis | JP | 19 Jan 1967 | |
Taeniasis | JP | 19 Jan 1967 | |
Anemia | - | - | - |
Sciatica | - | - | - |
Trigeminal Neuralgia | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | US | 01 Mar 2012 |